Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loratadine PPK Study in Japanese Pediatric and Adult Patients
NCT00730912Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2008
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of loratadine in perennial allergic rhinitis (PAR), sponsored by Merck & Co.. Started Jun 2008; status: completed.
02
Drugs
loratadine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00730912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00730912.